Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

EGFR

Items 41-50 of 71

Page
per page
  1. Varlitinib (ARRY334543)
    A8365 Varlitinib (ARRY334543)
    Summary: ErbB inhibitor
      ≥23.35 mg/mL
  2. AG-1478
    A8357 AG-1478
    Target: EGFR
    Summary: EGFR inhibitor,potent and selective
      insoluble in H2O; ≥15.8 mg/mL
  3. Neratinib (HKI-272)
    A8322 Neratinib (HKI-272)
     3 Citation
    Target: EGFR
    Summary: HER2/EGFR inhibitor,potent and irreversible
      insoluble in H2O; ≥13.93 mg/mL
  4. Dacomitinib (PF299804, PF299)
    A8319 Dacomitinib (PF299804, PF299)
    Target: ErbB
    Summary: HER inhibitor
      ≥23.5 mg/mL
  5. Afatinib (BIBW2992)
    A8247 Afatinib (BIBW2992)
     2 Citation
    Target: EGFR
    Summary: Irreversible EGFR/HER2 inhibitor
      ≥24.3 mg/mL
  6. Erlotinib Hydrochloride
    A8234 Erlotinib Hydrochloride
     2 Citation
    Summary: Selective EGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥6.44 mg/mL
  7. Gefitinib (ZD1839)
    A8219 Gefitinib (ZD1839)
     16 Citation
    Target: EGFR
    Summary: Selective EGFR inhibitor
      ≥22.34 mg/mL
  8. Lapatinib
    A8218 Lapatinib
     7 Citation
    Target: ErbB
    Summary: EGFR/HER2 inhibitor,potent,selective and reversible
      ≥29.05 mg/mL
  9. PD153035 hydrochloride
    A8199 PD153035 hydrochloride
     1 Citation
    Target: EGFR
    Summary: Potent EGFR inhibitor
      insoluble in EtOH; insoluble in H2O; ≥3.97 mg/mL
  10. Compound 56
    A8197 Compound 56
     1 Citation
    Target: EGFR
    Summary: REGFR inhibitor
      insoluble in H2O; ≥16.95 mg/mL

Items 41-50 of 71

Page
per page